Andrew Joseph

Andrew Joseph is a seasoned journalist with experience in general assignment reporting and a focus on health policy and science. He has worked for STAT since its launch in 2015, first at the Boston headquarters before relocating to London as the Europe correspondent. As part of the STAT team covering the Covid-19 pandemic, he was named a Pulitzer Prize finalist. Prior to joining STAT, Joseph worked for the San Antonio Express-News and San Francisco Chronicle. He is a Dartmouth College graduate.

Biography:  https://www.statnews.com/staff/andrew-joseph/

81%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

92%

Examples:

  • Andrew Joseph is a Europe correspondent for STAT, covering health and science news. He has previously worked as a general assignment reporter in STAT's Boston headquarters and has been part of the team that was named a Pulitzer Prize finalist for early coverage of the Covid-19 pandemic.
  • Joseph has experience covering various topics, including crime, but his focus is primarily on health policy and science. This suggests a potential bias towards these subjects.

Conflicts of Interest

75%

Examples:

  • There is no direct evidence of conflict of interest in Andrew Joseph's reporting.

Contradictions

85%

Examples:

  • Five adults with early-onset dementia symptoms may be connected to a now-discontinued human growth hormone medical treatment that they received decades ago as children. Possible transmission of amyloid beta protein, which is a key component of Alzheimer's disease when it forms plaques in the brain, may have contributed to their dementia symptoms.
  • The article discusses five cases of Alzheimer's disease that were transmitted from a medical procedure involving growth hormone taken from human cadavers. The patients developed symptoms in their 40s and 50s, which is younger than the typical age for Alzheimer's disease.
  • The study provides the first reported evidence of medically acquired Alzheimer's disease in living people. The new study emphasizes the importance of sterilization and decontamination of instruments in between surgeries to prevent accidental transmissions via other medical procedures.

Deceptions

75%

Examples:

  • The article presents the idea that transmitted Alzheimer's disease is a scientific anomaly when in fact there have been cases of iatrogenic CJD (a prion-like mechanism) linked to growth hormone treatment.
  • The authors present limited information and data, making it difficult for readers to fully understand the implications of their findings.

Recent Articles

Finland Leads the Way: Offering Avian Influenza Vaccines to At-Risk Individuals Amidst Rising Cases and EU Procurement of 40 Million Doses

Finland Leads the Way: Offering Avian Influenza Vaccines to At-Risk Individuals Amidst Rising Cases and EU Procurement of 40 Million Doses

Broke On: Wednesday, 05 June 2024 Finland becomes the first country to offer vaccines against avian influenza, with limited doses available for at-risk groups. The EU secures 40 million doses as cases rise and concerns about human health intensify. Finland's vaccine is based on a different strain but offers protection against H5N1, while scientists continue to study potential implications of a bird flu pandemic.
New Study Links HGH from Cadavers to Alzheimer's Disease in Some Patients

New Study Links HGH from Cadavers to Alzheimer's Disease in Some Patients

Broke On: Wednesday, 31 January 2024 A new study published in Nature Medicine has linked human growth hormone (HGH) treatments from cadavers to Alzheimer's disease in some patients who received it as children decades ago. The study found that five adults with early-onset dementia symptoms had possible transmission of amyloid beta protein, which is a key component of Alzheimer's disease when it forms plaques in the brain. This suggests that HGH from cadavers may have contributed to their dementia symptoms. The study emphasizes the importance of sterilization and decontamination of instruments in between surgeries to prevent accidental transmissions via other medical procedures.